Ahm Robert, Rottmann Nina, Skovbakke Søren Jensen, Helmark Charlotte, Vasilescu Christina Antoinetta, Pedersen Susanne S
Department of Psychology, University of Southern Denmark, Odense, Denmark.
Department of Cardiology, Zealand University Hospital, Denmark.
Internet Interv. 2025 Jul 19;41:100864. doi: 10.1016/j.invent.2025.100864. eCollection 2025 Sep.
Ischemic heart disease (IHD) is a leading cause of mortality that is very often accompanied by comorbid anxiety and depression. The aim of this study was to develop MY-CHOICE, a guided internet-based psychological intervention for the treatment of anxiety and depression in IHD patients using patient and public involvement (PPI).
We used the framework recommended by the Medical Research Counsel for developing and evaluating complex interventions to develop MY-CHOICE. Patient representatives with IHD and comorbid anxiety and/or depression ( = 5) were recruited from Odense University Hospital and invited to a series of workshops to gather their feedback on the MY-CHOICE prototype. The workshops used the MUST method for the planning, facilitation, data generation and analysis. The MoSCoW principles were used to help the patient representatives in prioritizing among their suggestions. Data were collected by means of audio recordings and observational notes.
This study revealed the need for new treatment modules, including how to manage chronic pain and how to navigate the healthcare system. The patient representatives emphasized the importance of shared decision-making in customizing treatment to individual preferences and needs.
MY-CHOICE represents a patient focused approach to improving mental health in patients with IHD. By integrating patient feedback through PPI, MY-CHOICE aims to deliver tailored psychological treatment, possibly increasing relevance and adherence.
This study highlights the necessity of addressing comprehensive needs in IHD patients, including chronic pain, and emphasizes the importance of using shared decision-making to optimize patient engagement and adherence to treatment.
缺血性心脏病(IHD)是导致死亡的主要原因,经常伴有焦虑和抑郁等合并症。本研究的目的是开发MY-CHOICE,这是一种基于互联网的指导性心理干预措施,利用患者和公众参与(PPI)来治疗IHD患者的焦虑和抑郁。
我们使用医学研究委员会推荐的框架来开发和评估复杂干预措施,以开发MY-CHOICE。从欧登塞大学医院招募了患有IHD且伴有焦虑和/或抑郁的患者代表(n = 5),并邀请他们参加一系列研讨会,以收集他们对MY-CHOICE原型的反馈。研讨会使用MUST方法进行规划、促进、数据生成和分析。MoSCoW原则用于帮助患者代表在其建议中进行优先级排序。数据通过录音和观察记录收集。
本研究揭示了对新治疗模块的需求,包括如何管理慢性疼痛以及如何在医疗系统中导航。患者代表强调了共同决策在根据个人偏好和需求量身定制治疗方面的重要性。
MY-CHOICE代表了一种以患者为中心的方法,用于改善IHD患者的心理健康。通过PPI整合患者反馈,MY-CHOICE旨在提供量身定制的心理治疗,可能会提高相关性和依从性。
本研究强调了满足IHD患者全面需求(包括慢性疼痛)的必要性,并强调了使用共同决策来优化患者参与度和治疗依从性的重要性。